PPA
SGMO

Parametric Portfolio Associates’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Parametric Portfolio Associates’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.32M Buy
227,772
+83,636
+58% +$497K ﹤0.01% 2646
2021
Q4 		$1.08M Sell
144,136
-7,474
-5% -$64.9K ﹤0.01% 2746
2021
Q3 		$1.37M Sell
151,610
-20,848
-12% -$206K ﹤0.01% 2651
2021
Q2 		$2.06M Sell
172,458
-8,169
-5% -$92.5K ﹤0.01% 2418
2021
Q1 		$2.26M Sell
180,627
-46,451
-20% -$626K ﹤0.01% 2702
2020
Q4 		$3.54M Sell
227,078
-4,363
-2% -$51.1K ﹤0.01% 2303
2020
Q3 		$2.19M Buy
231,441
+22,104
+11% +$239K ﹤0.01% 2462
2020
Q2 		$1.88M Buy
209,337
+39,478
+23% +$366K ﹤0.01% 2539
2020
Q1 		$1.08M Buy
169,859
+76,004
+81% +$564K ﹤0.01% 2754
2019
Q4 		$786K Sell
93,855
-6,599
-7% -$60.7K ﹤0.01% 3177
2019
Q3 		$909K Buy
100,454
+8,772
+10% +$98.4K ﹤0.01% 3077
2019
Q2 		$987K Buy
91,682
+6,867
+8% +$73K ﹤0.01% 3053
2019
Q1 		$809K Sell
84,815
-6,418
-7% -$65.5K ﹤0.01% 3135
2018
Q4 		$1.05M Sell
91,233
-19,118
-17% -$237K ﹤0.01% 2957
2018
Q3 		$1.87M Sell
110,351
-18,829
-15% -$286K ﹤0.01% 2768
2018
Q2 		$1.83M Sell
129,180
-54,536
-30% -$906K ﹤0.01% 2746
2018
Q1 		$3.49M Buy
183,716
+46,927
+34% +$1M ﹤0.01% 2192
2017
Q4 		$2.24M Buy
136,789
+108,202
+379% +$1.61M ﹤0.01% 2529
2017
Q3 		$429K Buy
+28,587
New +$316K ﹤0.01% 3503
2017
Q2 		– Sell
-111,136
Closed -$578K – 4027
2017
Q1 		$578K Buy
+111,136
New +$446K ﹤0.01% 3127
2016
Q3 		– Sell
-148,721
Closed -$861K – 3799
2016
Q2 		$861K Sell
148,721
-3,468
-2% -$22.1K ﹤0.01% 2930
2016
Q1 		$921K Buy
+152,189
New +$914K ﹤0.01% 2980

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Parametric Portfolio Associates's SGMO Position: Q1 2022 in Review

Parametric Portfolio Associates increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 58% in Q1 2022, buying an estimated $497K and bringing the position to 227,772 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2646.

Parametric Portfolio Associates first reported a position in SGMO in Q1 2016 and has held it in 22 quarters since. The position peaked at $3.54M in Q4 2020. 195 funds tracked by Wall St. Rank hold SGMO as of Q1 2022.

  • Parametric Portfolio Associates held 227,772 shares of SANGAMO THERAPEUTICS INC worth $1.32M as of Q1 2022.
  • Parametric Portfolio Associates bought 83,636 SANGAMO THERAPEUTICS INC shares in Q1 2022, an estimated $497K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2646 holding.
  • Parametric Portfolio Associates first reported a position in SANGAMO THERAPEUTICS INC in Q1 2016 and has held it in 22 quarters since.
  • Parametric Portfolio Associates's SANGAMO THERAPEUTICS INC position peaked at $3.54M in Q4 2020.
  • 195 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.